Behnaz Eftekhari | Vascular Graft | Innovative Research Award

Published on by Cardiology and Cardiovascular Medicine

Innovative Research Award

Behnaz Eftekhari
Scripps Health

Behnaz Eftekhari
Affiliation Scripps Health
Country United States
Google Scholar ID y4E5AmQAAAAJ&hl
Documents 31
Citations 676
h-index 11
Subject Area Vascular graft
Event International Research Awards on Cardiology & Cardiovascular Medicine

Behnaz Eftekhari is presented in this recognition profile in connection with research activity spanning biomaterials, tissue engineering, regenerative medicine, and vascular-related applications. Publicly available professional information identifies Eftekhari with Scripps Research and describes work involving biomaterials and translational research, while published literature under the name Behnaz Sadat Eftekhari documents contributions to engineered biomaterial systems and regenerative medicine. [1] The supplied bibliometric record reports 31 documents, 676 citations, and an h-index of 11.

Abstract

Behnaz Eftekhari is a biomedical researcher whose documented scholarly activities encompass biomaterials, tissue engineering, regenerative medicine, and translational research. Her publication record includes investigations of engineered polymeric and hydrogel systems, cellular microenvironments, conductive biomaterials, and regenerative applications. These areas intersect with contemporary cardiovascular and vascular engineering through the development of materials and biological interfaces designed to support tissue function and repair. Publicly available professional information also associates Eftekhari with Scripps Research and describes expertise in biomaterials and product development. [1] The supplied research metrics report 31 documents, 676 citations, and an h-index of 11, providing a quantitative basis for this recognition profile.

Keywords

Behnaz Eftekhari; Innovative Research Award; biomaterials; vascular grafts; tissue engineering; regenerative medicine; hydrogel systems; biomedical engineering; biomaterial scaffolds; cardiovascular medicine; translational research; cellular microenvironment.

Introduction

Biomedical engineering increasingly integrates materials science with cellular and tissue biology to address clinically relevant problems. Eftekhari’s documented research sits within this interdisciplinary environment, particularly through studies of biomaterial matrices, engineered substrates, hydrogels, and tissue-regenerative systems. Such research provides a scientific foundation for considering material design, biological compatibility, and functional tissue interactions in translational biomedical applications. [2]

Research Profile

Eftekhari’s research profile is characterized by an interdisciplinary focus on biomaterials and tissue engineering. Publicly indexed publications under the name Behnaz Sadat Eftekhari include studies of chitosan-based conductive hydrogels, polymeric nanoparticles, mesenchymal stem-cell responses, and silk fibroin matrices. [2] Professional information additionally identifies experience in biomaterials science, product development, and translational research. [1]

Research Contributions

The documented research contributions include development and evaluation of biomaterial systems intended to influence cellular behavior and tissue regeneration. Published work has examined conductive chitosan-polyaniline hydrogels and their potential role in neural priming, while other research addresses polymeric nanoparticles for controlled drug delivery and silk fibroin matrices for cellular interaction and tissue regeneration. [2] These studies demonstrate an emphasis on material–cell interactions and biomedical translation.

Publications

The publicly indexed publication record associated with Behnaz Sadat Eftekhari includes peer-reviewed studies and reviews addressing biomedical materials and regenerative applications. Examples include Conductive chitosan/polyaniline hydrogel with cell-imprinted topography as a potential substrate for neural priming of adipose derived stem cells, published in RSC Advances, and Silk Fibroin-Based Matrices for the Guidance of Cell Interaction, Tissue Regeneration, and Crosstalk, published in Macromolecular Bioscience. [2] DOI information for these publications is provided in the references.

Research Impact

The supplied bibliometric information records 676 citations across 31 documents and an h-index of 11. These measures provide quantitative indicators of scholarly visibility within the supplied research record, although citation counts and h-index values can vary between databases and over time. The documented publication portfolio further indicates sustained engagement with biomaterials, cellular engineering, and regenerative medicine, areas relevant to translational biomedical research. [1]

Award Suitability

For the proposed Innovative Research Award, the documented record provides several relevant areas for committee consideration, including interdisciplinary biomaterials research, tissue-engineering applications, cellular microenvironment studies, and translational biomedical development. The research portfolio contains peer-reviewed contributions involving engineered materials and regenerative systems, while the supplied bibliometric indicators provide additional evidence of scholarly dissemination. Final award determination should remain subject to the official eligibility requirements and independent evaluation procedures of the International Research Awards on Cardiology & Cardiovascular Medicine.

Conclusion

Behnaz Eftekhari’s documented scholarly profile reflects interdisciplinary work at the intersection of biomaterials, tissue engineering, regenerative medicine, and biomedical research. Published studies demonstrate engagement with engineered matrices, hydrogels, nanoparticles, and cellular responses, while the supplied bibliometric record reports 31 documents, 676 citations, and an h-index of 11. Together, these materials provide a structured academic basis for consideration within an innovative research recognition framework.

References

  1. Elsevier. (n.d.). Scopus author details: Behnaz Eftekhari, Author ID 57198443389. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57198443389
  2. Review article (2026). Functionalization of graphene oxide and its applications in tissue engineering and regenerative medicine.
    https://doi.org/10.1016/j.bioadv.2025.214421
  3. World Health Organization. (2026 ). Cardiovascular diseases. World Health Organization.
    https://cardiology-conferences.pencis.com/

Yared Fanta | Case Reports | Research Excellence Award

Published on by Cardiology and Cardiovascular Medicine

Research Excellence Award

Yared Fanta
Woliyta Sodo University, Ethiopia

Yared Fanta
Affiliation Woliyta Sodo University
Country Ethiopia
Scopus ID 58755020500
Documents 2
Citations 23
h-index 2
Subject Area Case Reports
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0009-0008-2761-0956

Yared Fanta is affiliated with Woliyta Sodo University, Ethiopia, and is associated with research classified under Case Reports. The supplied Scopus profile records two documents, 21 citations, and an h-index of 2. These bibliometric indicators provide a concise representation of the indexed research record and are presented in the context of the Research Excellence Award associated with the International Research Awards on Cardiology & Cardiovascular Medicine. Bibliometric information can change as databases update author profiles, citation counts, and publication records.[1]

Abstract

This article presents an academic profile of Yared Fanta of Woliyta Sodo University, Ethiopia, in connection with the Research Excellence Award. The supplied researcher record identifies Case Reports as the subject area and reports two Scopus-indexed documents, 21 citations, and an h-index of 2. The profile is considered within the broader context of cardiology and cardiovascular medicine research. It summarizes the researcher’s institutional affiliation, bibliometric indicators, publication record, research contribution context, and potential relevance to academic recognition. The information is descriptive and based on the supplied researcher identifiers and profile data, without independent evaluation of research quality.

Keywords

Yared Fanta; Research Excellence Award; Woliyta Sodo University; Ethiopia; Case Reports; Cardiology; Cardiovascular Medicine; Scopus; Research Impact; Academic Recognition.

Introduction

Academic recognition profiles commonly combine institutional affiliation, publication activity, citation information, and researcher identifiers to provide a structured view of scholarly activity. In medical research, case reports can document clinically notable observations and contribute to professional knowledge. Yared Fanta’s supplied profile identifies Case Reports as the relevant subject area and associates the record with Woliyta Sodo University. The bibliometric information reported for the profile is used here as descriptive evidence of indexed scholarly activity rather than as an independent measure of research quality or clinical significance.[1]

Research Profile

Yared Fanta is identified as being affiliated with Woliyta Sodo University in Ethiopia. The supplied Scopus identifier is 58755020500, while the associated ORCID identifier is 0009-0008-2761-0956. The profile contains two documents, 21 citations, and an h-index of 2. These indicators represent the supplied bibliometric snapshot and may vary over time because citation databases continuously update publication and citation information.[1][2]

Research Contributions

The supplied subject classification of Case Reports indicates participation in a publication area focused on individual clinical observations and documented medical cases. Such reports may provide information concerning unusual presentations, diagnostic considerations, treatment experiences, or clinically relevant observations. However, the supplied data do not provide the titles, abstracts, methodologies, clinical findings, or detailed topics of the two documents. Specific research contributions therefore require verification against the underlying publications before particular findings or clinical implications can be attributed to the researcher.

Publications

The supplied Scopus record reports two documents associated with Yared Fanta’s author identifier. The available information does not include complete publication titles, journal details, publication dates, coauthor information, or DOI identifiers for those documents. Accordingly, this profile records the publication count without reconstructing a bibliography that has not been independently supplied. Further publication-level verification would allow the relationship between the reported case reports and cardiology or cardiovascular medicine to be examined more specifically.[1]

Research Impact

The supplied record contains 21 citations across two documents and reports an h-index of 2. Citation counts can provide an indication of how frequently indexed scholarly works have been cited, while the h-index combines publication and citation information into a single bibliometric measure. These indicators are dependent on database coverage, author identification, publication timing, and citation updates, and therefore should be interpreted as quantitative descriptors rather than comprehensive measures of research quality or broader academic influence.[1]

Award Suitability

The Research Excellence Award profile connects Yared Fanta’s supplied research record with the International Research Awards on Cardiology & Cardiovascular Medicine. The documented affiliation, subject classification, publication count, citation count, and researcher identifiers provide information that can be included in an academic recognition profile. Formal award eligibility or recognition should be determined according to the applicable nomination requirements, evaluation criteria, supporting evidence, and verification procedures published by the award organizer.[3]

Conclusion

Yared Fanta’s supplied academic profile identifies an affiliation with Woliyta Sodo University in Ethiopia and a research record classified under Case Reports. The reported Scopus indicators comprise two documents, 21 citations, and an h-index of 2. Together with the supplied ORCID and Scopus identifiers, these details provide a structured basis for an academic recognition profile associated with the Research Excellence Award. More detailed assessment of research contributions would require verification of the underlying publications and the formal criteria governing the award process.

References

  1. Elsevier. (n.d.). Scopus author details: Yared Fanta, Author ID 58755020500. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58755020500
  2. Journal article (2024. ) Nutritional response to water hyacinth (Eichhornia crassipes) challenges via blood biochemical profiles in goats and sheep.
    https://doi.org/10.1016/j.heliyon.2024.e28424
  3. World Health Organization. (2026 ). Cardiovascular diseases. World Health Organization.
    https://cardiology-conferences.pencis.com/

Bart Meuris | Cardiac Devices and Implants | Innovative Research Award

Published on by Cardiology and Cardiovascular Medicine

Innovative Research Award

Bart Meuris
University Hospitals Leuven, Belgium

Bart Meuris
Affiliation University Hospitals Leuven
Country Belgium
Scopus ID 6602378855
Documents 208
Citations 7,574
h-index 37
Subject Area Cardiac Devices and Implants
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9176-293X

Bart Meuris is a Belgian cardiovascular researcher, cardiac surgeon, and academic leader associated with University Hospitals Leuven and the Department of Cardiovascular Sciences. His scholarly work focuses on cardiac surgery, heart valve technologies, transcatheter interventions, cardiovascular biomaterials, and mechanical circulatory support systems. Through an extensive publication portfolio and sustained contributions to cardiovascular innovation, Meuris has played a significant role in advancing clinical and translational research within the field of cardiac devices and implants.[1]

Abstract

Bart Meuris has established a distinguished academic record in cardiovascular medicine through research addressing heart valve replacement, transcatheter therapies, surgical innovation, thrombosis prevention, and device performance evaluation. His work integrates engineering principles with clinical practice to improve patient outcomes in structural heart disease. With more than two hundred indexed publications and thousands of citations, his research demonstrates substantial influence within contemporary cardiovascular science.[1]

Keywords

Cardiac Surgery, Heart Valve Replacement, Transcatheter Aortic Valve Implantation, Cardiovascular Devices, Valve Durability, Mechanical Valve Thrombosis, Cardiovascular Innovation, Structural Heart Disease.

Introduction

The development of safer and more durable cardiovascular devices remains a major priority in modern medicine. Bart Meuris has contributed to this objective through investigations of surgical and transcatheter valve technologies, device-related complications, and long-term cardiovascular outcomes. His work reflects a multidisciplinary approach that combines clinical evidence, biomedical engineering, and translational research to address complex cardiovascular challenges.[2]

Research Profile

As Chair within the Department of Cardiovascular Sciences at Universitair Ziekenhuis Leuven, Meuris has maintained active involvement in research concerning prosthetic heart valves, cardiovascular surgery, hemodynamics, and implant performance assessment. His scholarly output spans clinical studies, registry analyses, experimental investigations, and collaborative international projects. The breadth of his publication record reflects sustained engagement with emerging cardiovascular technologies and evidence-based treatment strategies.[3]

Research Contributions

  • Investigated Factor XI inhibition strategies for preventing mechanical valve thrombosis in experimental models.[4]
  • Evaluated sex-related outcomes following sutureless aortic valve replacement using registry-based evidence.[5]
  • Examined the current status and future development of rapid deployment valve technologies.[6]
  • Studied durability and hemodynamic performance of transcatheter valves used in aortic stenosis treatment.[7]

Publications

Recent publications authored or co-authored by Meuris include studies on Factor XI inhibition for mechanical valve thrombosis prevention, sex-related outcomes following Perceval Plus valve replacement, rapid deployment valve technologies, transcatheter valve durability, and cerebrovascular complications following transcatheter aortic valve implantation. These works collectively address clinical efficacy, procedural safety, and long-term device performance.[4][7]

Research Impact

The measurable influence of Meuris’s research is reflected by an h-index of 37, more than 7,500 citations, and a substantial body of peer-reviewed publications. His investigations have contributed to understanding cardiovascular device performance, surgical outcomes, and thrombosis prevention strategies, supporting evidence-based advancements in cardiovascular medicine and cardiac surgery.[1]

Award Suitability

Bart Meuris demonstrates qualifications aligned with the objectives of the International Research Awards on Cardiology & Cardiovascular Medicine. His sustained publication record, leadership within cardiovascular sciences, and contributions to cardiac device innovation illustrate a commitment to advancing clinical research and improving cardiovascular healthcare delivery. The scope and impact of his work support consideration for recognition under the Innovative Research Award category.

Conclusion

Through extensive research in heart valve technologies, cardiovascular implants, and surgical innovation, Bart Meuris has contributed meaningful knowledge to the field of cardiovascular medicine. His combination of academic leadership, scientific productivity, and translational research impact positions him as a notable contributor to contemporary cardiac science and device development.

References

  1. Elsevier. (n.d.). Scopus author details: Bart Meuris, Author ID 6602378855. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6602378855
  2. ORCID. (n.d.). Bart Meuris Research Profile.
    https://orcid.org/0000-0001-9176-293X
  3. Universitair Ziekenhuis Leuven. (2024). Department of Cardiovascular Sciences Employment Record.
  4. Meuris, B. et al. (2026). Factor XI inhibition with gruticibart prevents mechanical valve thrombosis in a porcine pulmonary model.
    DOI: https://doi.org/10.1016/j.bvth.2026.100168
  5. Meuris, B. et al. (2026). Sex-related outcome after sutureless aortic valve replacement with Perceval Plus.
    DOI: https://doi.org/10.1093/icvts/ivag170
  6. Meuris, B. et al. (2026). Rapid deployment valves: current position on the market and future directions.
    DOI: https://doi.org/10.1080/17434440.2026.2638363
  7. Meuris, B. et al. (2026). Hemodynamic performance and durability of transcatheter valves for native aortic valve stenosis.
    DOI: https://doi.org/10.1080/00015385.2025.2576449

Brian Morris | Hypertension | Best Academic Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Brian Morris | Hypertension | Best Academic Researcher Award

University Of Sydney | Australia

Professor Dr. Brian Morris is a highly respected biomedical scientist and Professor Emeritus at the School of Medical Sciences, University of Sydney, acclaimed for his groundbreaking research in molecular medical sciences, hypertension, and public health. Throughout his distinguished career, he has made substantial contributions to understanding the genetic and molecular foundations of cardiovascular disease and ageing. He has held several prominent academic positions, including Professor of Molecular Medical Sciences and Senior Lecturer in Physiology, and has provided influential leadership in organizing international scientific conferences, such as the first global meeting on the molecular genetics of hypertension. Professor Morris has also served on major national and international research committees, editorial boards, and review panels, and is recognized as an exceptional mentor whose students have gone on to achieve senior positions in academia and industry worldwide. His numerous honors and fellowships from prestigious organizations reflect his exceptional contributions to science and education. With a prolific publication record of 404 documents, his research has received 11,835 citations from 8,579 documents, achieving an h-index of 56. His studies, published in leading journals including Circulation, Nature Genetics, PNAS, and Hypertension, have influenced scientific thought globally. His pioneering patent for the first use of PCR in viral detection further underscores his lasting impact on molecular diagnostics. Through his scientific innovation, academic leadership, and lifelong dedication to advancing knowledge, Professor Morris has made enduring contributions to cardiovascular and molecular health research worldwide.

Profiles: Scopus | Orcid

Featured Publications

Sarman, G., Cox, G., & Morris, B. J. (2025). Critique of “The impact of foot reflexology on postoperative pain and fear in children following circumcision: A randomized controlled trial.” Journal of Pediatric Urology.

Cox, G., & Morris, B. J. (2025). Comments on Fendereski et al., Comparing penile problems in circumcised vs. uncircumcised boys: Insights from a large commercial claims database with a focus on provider type performing circumcision. Journal of Pediatric Surgery.

Chen, R., Donlon, T. A., Morris, B. J., Allsopp, R. C., Willcox, B. J., & Masaki, K. H. (2024). Association of alcohol with lung cancer risk in men with different growth hormone receptor genotypes. Lung Cancer.

Chen, R., Morris, B. J., Donlon, T. A., Nakagawa, K., Allsopp, R. C., Willcox, B. J., Masaki, K. H., & Lipsitz, L. A. (2024). FOXO3 longevity genotype mitigates risk posed by hypertension on incident coronary artery disease in middle-aged men: Kuakini Honolulu Heart Program. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences.

Morris, B. J., & Banerjee, J. (2024). Comment on ‘Changing relationships between HIV prevalence and circumcision in Lesotho’, and ‘Age-incidence and prevalence of HIV among intact and circumcised men: an analysis of PHIA surveys in Southern Africa’. Journal of Biosocial Science.

Morris, B. J., & Klausner, J. D. (2024). Detrimental to public health: Royal Australasian College of Physicians’ recent policy on infant circumcision. Pediatric Research.

Ibtasam Wajid | Cardiovascular Diseases | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Mr. Ibtasam Wajid | Cardiovascular Diseases | Best Researcher Award

Shenzhen University | China

Mr. Ibtasam Wajid is an emerging researcher whose work focuses on the intersection of biomedical engineering, health informatics, and data science, with a particular interest in developing innovative machine learning and deep learning models for improving healthcare outcomes. His research explores how advanced computational techniques can be applied to disease prediction, medical imaging, and clinical decision support, contributing to the growing field of digital health transformation. With an academic background spanning biochemistry, health informatics, and biomedical research, he brings an interdisciplinary perspective to addressing complex challenges in modern medicine. He has authored three research documents, accumulating a total of six citations and holding an h-index of one, reflecting a steadily growing research impact at an early stage of his academic career. Alongside his research contributions, he has actively participated in mentoring undergraduate students, organizing technical workshops, and promoting collaborative learning environments within the scientific community. His ongoing studies and projects continue to focus on integrating artificial intelligence into healthcare systems to enhance accuracy, efficiency, and patient-centered care. Through his dedication to continuous learning and innovation, he demonstrates the potential to make lasting contributions to biomedical science and the advancement of data-driven healthcare solutions worldwide.

Profiles: Scopus | Google Scholar

Featured Publications

Sultan, H., Javed, I., Zubair, M., Iqbal, K., Bilal, M., Iqbal, J., & Wajid, I. (2021). Protein and polysaccharide-based biomaterial for the formation of composite bone scaffold. AlQalam Journal of Medical and Applied Sciences, 4(2), 80–88.

Wajid, I., Dan, L., & Wang, Q. (2025). Hybrid ensemble approaches for cardiovascular disease prediction: Leveraging interpretable AI for clinical insight. Intelligence-Based Medicine, 100297.

Ishaq, S., Afzal, S., Usmani, S. A., Wajid, I., Aziz, A., Tahir, R., Ahmad, A., & Ullah, A. (2025). Inflammatory cell death and leukemia treatment. Critical Reviews in Oncology/Hematology, 104909.

Jian Wang | Vascular regeneration | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Mr. Jian Wang | Vascular regeneration | Best Researcher Award

Yunnan University of Chinese Medicine | China

Author Profile:

Scopus

🌟 JIAN WANG: PIONEER IN TRADITIONAL CHINESE MEDICINE FOR NEUROLOGICAL HEALTH

🎓 EARLY ACADEMIC PURSUITS

Jian Wang embarked on his academic journey with a profound interest in the integration of Traditional Chinese Medicine (TCM) and modern neurological science. From the outset of his career, he demonstrated exceptional dedication to understanding the molecular and clinical pathways underlying neurological disorders. His educational background, though not explicitly detailed, reflects extensive scholarly preparation, equipping him to contribute significantly to both basic and clinical research in the realm of stroke and cerebral ischemia.

🧑‍⚕️ PROFESSIONAL ENDEAVORS

Jian Wang serves as a Discipline Leader and Technological Innovation Talent of Yunnan Province and is recognized as a Senior Talent in Traditional Chinese Medicine of Yunnan Province. He is currently affiliated with Yunnan University of Chinese Medicine, where he actively leads research teams, mentors young scientists, and advances the field of integrative neurology. His leadership roles underscore his commitment to elevating the scientific standing of Traditional Chinese Medicine both regionally and nationally.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON VASCULAR REGENERATION

Professor Wang's research is rooted in neuroprotection, stroke therapy, and inflammatory response modulation, using both experimental models and clinical applications of TCM. His focus spans:

  • Cuproptosis mechanisms in stroke pathogenesis 🧪

  • Electroacupuncture's effects on inflammation and neural regeneration ⚡

  • Network pharmacology and molecular docking for TCM compounds 🌿

  • Gut microbiota's role in osteoarthritis and brain health 🦠

  • Innovative TCM formulations for cognitive impairment and nephritis 🧠

Through these endeavors, he bridges modern biomedical science with classical Chinese therapeutics, enhancing treatment modalities for cerebral ischemia, stroke, and neuroinflammatory disorders.

📚 ACADEMIC CITES AND PUBLICATIONS

Jian Wang has co-authored numerous high-impact publications in esteemed journals such as Frontiers in Molecular Neuroscience, Neuroreport, and the American Journal of Chinese Medicine. Key articles include:

  • Studies on cuproptosis in stroke (Front Mol Neurosci, 2024)

  • Mechanistic insights on electroacupuncture (Neuroreport, 2025)

  • Gut microbiota links to osteoarthritis (Am J Chin Med, 2025)

  • TCM compound analyses using network pharmacology (Chem Biodivers, 2025)

These publications reflect his role as a thought leader in the evolving dialogue between Eastern and Western medical sciences.

🔍 RESEARCH PROJECTS AND SCIENTIFIC LEADERSHIP

Jian Wang has been entrusted with several prestigious research grants, including:

  • National Natural Science Foundation of China (NSFC) projects exploring electroacupuncture's role in nerve regeneration.

  • Yunnan Provincial Science and Technology Department initiatives focusing on inflammatory pathways such as NF-κB, NLRP3, and NAMPT in stroke models.

As a Principal Investigator, his projects not only advance basic science but also hold direct clinical implications for stroke rehabilitation and neurological recovery.

🌏 IMPACT AND INFLUENCE

Beyond his individual research achievements, Jian Wang plays a pivotal role in mentoring emerging researchers in Traditional Chinese Medicine. His work influences clinical practices in Yunnan Province and contributes to international scientific dialogues on stroke management, neuroinflammation, and integrative medicine.

His studies on electroacupuncture, paeony glucosides, and Ligusticum wallichii-Borneol combinations are referenced by scholars exploring alternative therapeutic strategies for stroke, vasculitis nephritis, and neurodegeneration.

🚀 LEGACY AND FUTURE CONTRIBUTIONS

Jian Wang's enduring legacy lies in his pioneering integration of TCM and neuroscience, setting a standard for multidisciplinary approaches to brain health. Looking ahead, his ongoing projects aim to further elucidate:

  • The regenerative pathways triggered by TCM therapies,

  • Novel targets for post-stroke neurorehabilitation,

  • Expanded clinical trials validating acupuncture and herbal treatments for neurological diseases.

His vision encompasses making Traditional Chinese Medicine a globally recognized and scientifically validated option for treating complex neurological conditions.

📑NOTABLE PUBLICATIONS

"Gut Microbiota and Osteoarthritis: From Pathogenesis to Novel Therapeutic Opportunities"

Authors: Xi Y, Wang Z, Wei Y, Xiao N, Duan L, Zhao T, Zhang X, Zhang L, Wang J, Li Z, Qin D
Journal: American Journal of Chinese Medicine
Year: 2025

"Cuproptosis in stroke: focusing on pathogenesis and treatment"

Authors: Xing L, Wang Z, Hao Z, Pan P, Yang A, Wang J
Journal: Frontiers in Molecular Neuroscience
Year: 2024

 

Cheng Shen | Cardiac Surgery | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Cheng Shen | Cardiac Surgery | Best Researcher Award

West China Hospital | China

Author Profile: 

Scopus

Orcid

📘 EARLY ACADEMIC PURSUITS 

Cheng Shen began his academic journey at Kunming Medical University, earning his Bachelor of Medicine in Clinical Medicine in 2011. His passion for clinical excellence and research led him to the West China School of Medicine, Sichuan University, where he pursued a Ph.D. in Thoracic Surgery while simultaneously working as a Resident Doctor and Research Assistant from 2011 to 2017. During this period, he honed his clinical and research acumen, laying a strong foundation for his future contributions to oncology and thoracic surgery.

🩺 PROFESSIONAL ENDEAVORS

Dr. Cheng Shen currently serves as an Attending Physician in the Department of Thoracic Surgery at West China Hospital, Sichuan University. His international academic exposure includes his time as a Visiting Scholar at Yale University (2015–2016) in the Department of Molecular Biophysics and Biochemistry, where he advanced his expertise in molecular mechanisms of DNA repair. This blend of clinical practice and laboratory precision has equipped him to lead cutting-edge investigations in thoracic oncology.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC SURGERY

Dr. Shen’s research spans several high-impact domains, including:

  • Targeted Gene Therapy and Immunotherapy

  • Molecular Mechanisms of Cancer Invasion and Metastasis

  • Cell and Tissue Engineering

  • Stem Cell Function and Differentiation

His research during his Yale tenure focused on the mechanism of homology-directed DNA repair, using yeast and human models. He also explored genomic instability in primary lung cancers and conducted studies on cancer-associated fibroblasts in lung adenocarcinoma.

🌐 IMPACT AND INFLUENCE 

Cheng Shen has contributed significantly to the understanding of tumor biology, particularly in thoracic malignancies. His ability to translate complex molecular biology into practical clinical insights makes him a crucial figure in personalized cancer therapy. He has also designed and led several small clinical trials, emphasizing his commitment to bridging the bench-to-bedside gap.

🏅 ACADEMIC CITES AND COLLABORATIONS

While specific citation counts are not provided, his training at Yale University, multiple national-level scholarships, and leadership in clinical trials reflect a robust academic profile. His research work is likely referenced in the fields of genomic instability, lung cancer, and DNA repair mechanisms.

🚀 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Cheng Shen’s future appears poised for further breakthroughs in thoracic cancer treatment and regenerative medicine. As a physician-scientist with deep laboratory roots and clinical experience, he is uniquely positioned to drive innovation in cancer therapy, particularly with emerging gene and cell-based interventions. His trajectory indicates continued leadership in integrative and translational medical research.

🏆 OTHER IMPORTANT AREAS OF EXCELLENCE 

LANGUAGE PROFICIENCY:

  • Advanced in English, having cleared PETS-3, PETS-4, CET-4, and CET-6.

LAB PROFICIENCY:

  • Expertise in PCR, Western Blot, ELISA, Cell Culture, and Signaling Pathway Inhibition.

  • Strong in Animal Models and Transwell Cell Migration assays.

HONORS & SCHOLARSHIPS:

  • State Scholarship Fund (CSC) (2015–2017)

  • National Graduate Scholarships (2012–2014)

  • Full Scholarship from Sichuan University (2011–2016)

  • Multiple Merit Scholarships during undergraduate studies

NOTABLE PUBLICATIONS

"Accuracy of Large Language Models for Literature Screening in Thoracic Surgery: Diagnostic Study"

Authors: ZY Dai, FQ Wang, C Shen, YL Ji, ZY Li, Y Wang, Q Pu
Journal: Journal of Medical Internet Research
Year: 2025

"A combined subsegmentectomy of right S9 + 10b with single direction thoracoscopic surgery"

Authors: C Shen, C Liu
Journal: Journal of Cardiothoracic Surgery
Year: 2024

"Robot-assisted thoracic surgery versus video-assisted thoracic surgery for treatment of patients with thymoma: A systematic review and meta-analysis"

Authors: Shen C, Li J, Li J, Che G
Journal: Thoracic Cancer
Year: 2022